A Phase 2b Diabetic Kidney Disease Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetic Kidney Disease

In brief

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease

Key facts

Study ID: NCT04170543
Run by: AstraZeneca
People needed: 609
Starts: 2019-11-18
Expected to finish: 2023-05-16
Last updated by the study team: 2024-07-10

Who can join

Age: 18 and older, up to 101. Sex: any. Healthy volunteers: not accepted.

Where it is running

Research Site — Huntsville, Alabama, United States
Research Site — Mesa, Arizona, United States
Research Site — Alhambra, California, United States
Research Site — Glendale, California, United States
Research Site — Granada Hills, California, United States
Research Site — Huntington Park, California, United States
Research Site — Northridge, California, United States
Research Site — Sacramento, California, United States
Research Site — San Diego, California, United States
Research Site — San Dimas, California, United States
Research Site — Vacaville, California, United States
Research Site — Fleming Island, Florida, United States
Research Site — Hialeah, Florida, United States
Research Site — Jacksonville, Florida, United States
Research Site — Miami, Florida, United States
Research Site — Atlanta, Georgia, United States
Research Site — Honolulu, Hawaii, United States
Research Site — Chicago, Illinois, United States
Research Site — Chicago, Illinois, United States
Research Site — Iowa City, Iowa, United States
Research Site — Manhattan, Kansas, United States
Research Site — Topeka, Kansas, United States
Research Site — Wichita, Kansas, United States
Research Site — Flint, Michigan, United States
Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.